A citation-based method for searching scientific literature

Simeon I Taylor, Jenny E Blau, Kristina I Rother, Amber L Beitelshees. Lancet Diabetes Endocrinol 2019
Times Cited: 18







List of co-cited articles
96 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



A review of the mechanism of action, metabolic profile and haemodynamic effects of sodium-glucose co-transporter-2 inhibitors.
Emily Brown, Surya P Rajeev, Daniel J Cuthbertson, John P H Wilding. Diabetes Obes Metab 2019
26
5

Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver.
Michihiro Matsumoto, Alessandro Pocai, Luciano Rossetti, Ronald A Depinho, Domenico Accili. Cell Metab 2007
404
5

Pancreatic glucose-dependent insulinotropic polypeptide (GIP) (1-30) expression is upregulated in diabetes and PEGylated GIP(1-30) can suppress the progression of low-dose-STZ-induced hyperglycaemia in mice.
Tsuyoshi Yanagimachi, Yukihiro Fujita, Yasutaka Takeda, Jun Honjo, Kuralay K Atageldiyeva, Yumi Takiyama, Atsuko Abiko, Yuichi Makino, Timothy J Kieffer, Masakazu Haneda. Diabetologia 2016
15
6


Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial.
David Fitchett, Silvio E Inzucchi, Christopher P Cannon, Darren K McGuire, Benjamin M Scirica, Odd Erik Johansen, Steven Sambevski, Stefan Kaspers, Egon Pfarr, Jyothis T George,[...]. Circulation 2019
71
5

Protective effects of SGLT2 inhibitor luseogliflozin on pancreatic β-cells in obese type 2 diabetic db/db mice.
Seizo Okauchi, Masashi Shimoda, Atsushi Obata, Tomohiko Kimura, Hidenori Hirukawa, Kenji Kohara, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto. Biochem Biophys Res Commun 2016
33
5

Absorption patterns of meals containing complex carbohydrates in type 1 diabetes.
D Elleri, J M Allen, J Harris, K Kumareswaran, M Nodale, L Leelarathna, C L Acerini, A Haidar, M E Wilinska, N Jackson,[...]. Diabetologia 2013
25
5

Carbohydrate counting accuracy and blood glucose variability in adults with type 1 diabetes.
A S Brazeau, H Mircescu, K Desjardins, C Leroux, I Strychar, J M Ekoé, R Rabasa-Lhoret. Diabetes Res Clin Pract 2013
86
5

Home Use of an Artificial Beta Cell in Type 1 Diabetes.
H Thabit, M Tauschmann, J M Allen, L Leelarathna, S Hartnell, M E Wilinska, C L Acerini, S Dellweg, C Benesch, L Heinemann,[...]. N Engl J Med 2015
243
5

Emphasis on carbohydrates may negatively influence dietary patterns in youth with type 1 diabetes.
Sanjeev N Mehta, Denise L Haynie, Laurie A Higgins, Natalie N Bucey, Alisha J Rovner, Lisa K Volkening, Tonja R Nansel, Lori M B Laffel. Diabetes Care 2009
41
5

Translating the A1C assay into estimated average glucose values.
David M Nathan, Judith Kuenen, Rikke Borg, Hui Zheng, David Schoenfeld, Robert J Heine. Diabetes Care 2008
871
5

Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes.
Firas H El-Khatib, Steven J Russell, Kendra L Magyar, Manasi Sinha, Katherine McKeon, David M Nathan, Edward R Damiano. J Clin Endocrinol Metab 2014
64
5

Post-breakfast closed-loop glucose control is improved when accompanied with carbohydrate-matching bolus compared to weight-dependent bolus.
A Haidar, D Farid, A St-Yves, V Messier, V Chen, D Xing, A-S Brazeau, C Duval, B Boulet, L Legault,[...]. Diabetes Metab 2014
16
6

Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.
Ahmad Haidar, Laurent Legault, Laurence Matteau-Pelletier, Virginie Messier, Maryse Dallaire, Martin Ladouceur, Rémi Rabasa-Lhoret. Lancet Diabetes Endocrinol 2015
72
5


Review on sodium-glucose cotransporter 2 inhibitor (SGLT2i) in diabetes mellitus and heart failure.
Akshyaya Pradhan, Shweta Vohra, Pravesh Vishwakarma, Rishi Sethi. J Family Med Prim Care 2019
5
20

Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide.
Jennifer L Sherr, Neha S Patel, Camille I Michaud, Miladys M Palau-Collazo, Michelle A Van Name, William V Tamborlane, Eda Cengiz, Lori R Carria, Eileen M Tichy, Stuart A Weinzimer. Diabetes Care 2016
39
5


A bihormonal closed-loop artificial pancreas for type 1 diabetes.
Firas H El-Khatib, Steven J Russell, David M Nathan, Robert G Sutherlin, Edward R Damiano. Sci Transl Med 2010
222
5


Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials.
Per-Henrik Groop, Paresh Dandona, Moshe Phillip, Pieter Gillard, Steven Edelman, Johan Jendle, John Xu, Markus F Scheerer, Fredrik Thoren, Nayyar Iqbal,[...]. Lancet Diabetes Endocrinol 2020
3
33

Adjuvant Liraglutide and Insulin Versus Insulin Monotherapy in the Closed-Loop System in Type 1 Diabetes: A Randomized Open-Labeled Crossover Design Trial.
Jeniece Trast Ilkowitz, Ranjitha Katikaneni, Martin Cantwell, Neesha Ramchandani, Rubina A Heptulla. J Diabetes Sci Technol 2016
12
8

Effect of carbohydrate counting and medical nutritional therapy on glycaemic control in Type 1 diabetic subjects: a pilot study.
G Scavone, A Manto, D Pitocco, L Gagliardi, S Caputo, L Mancini, F Zaccardi, G Ghirlanda. Diabet Med 2010
54
5

Empagliflozin (Jardiance): A Novel SGLT2 Inhibitor for the Treatment of Type-2 Diabetes.
Uche Anadu Ndefo, Nicole O Anidiobi, Efrah Basheer, Angie T Eaton. P T 2015
11
9

Efficacy of carbohydrate counting in type 1 diabetes: a systematic review and meta-analysis.
Kirstine J Bell, Alan W Barclay, Peter Petocz, Stephen Colagiuri, Jennie C Brand-Miller. Lancet Diabetes Endocrinol 2014
74
5


Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
Steven J Russell, Mallory A Hillard, Courtney Balliro, Kendra L Magyar, Rajendranath Selagamsetty, Manasi Sinha, Kerry Grennan, Debbie Mondesir, Laya Ekhlaspour, Hui Zheng,[...]. Lancet Diabetes Endocrinol 2016
103
5

Pharmacokinetics of insulin aspart in pump-treated subjects with type 1 diabetes: reproducibility and effect of age, weight, and duration of diabetes.
Ahmad Haidar, Daniela Elleri, Kavita Kumareswaran, Lalantha Leelarathna, Janet M Allen, Karen Caldwell, Helen R Murphy, Malgorzata E Wilinska, Carlo L Acerini, Mark L Evans,[...]. Diabetes Care 2013
30
5

Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report.
David M Maahs, Bruce A Buckingham, Jessica R Castle, Ali Cinar, Edward R Damiano, Eyal Dassau, J Hans DeVries, Francis J Doyle, Steven C Griffen, Ahmad Haidar,[...]. Diabetes Care 2016
96
5

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.
Richard M Bergenstal, Satish Garg, Stuart A Weinzimer, Bruce A Buckingham, Bruce W Bode, William V Tamborlane, Francine R Kaufman. JAMA 2016
277
5

Outpatient glycemic control with a bionic pancreas in type 1 diabetes.
Steven J Russell, Firas H El-Khatib, Manasi Sinha, Kendra L Magyar, Katherine McKeon, Laura G Goergen, Courtney Balliro, Mallory A Hillard, David M Nathan, Edward R Damiano. N Engl J Med 2014
325
5

The role of glucagon in the artificial pancreas.
Ahmad Haidar, Mohamed Raef Smaoui, Laurent Legault, Rémi Rabasa-Lhoret. Lancet Diabetes Endocrinol 2016
22
5


Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin-pump-treated patients with type 1 diabetes: The Lira Pump trial-a randomized, double-blinded, placebo-controlled trial.
Thomas F Dejgaard, Signe Schmidt, Christian S Frandsen, Dorte Vistisen, Sten Madsbad, Henrik U Andersen, Kirsten Nørgaard. Diabetes Obes Metab 2020
5
20

Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders.
Kevan C Herold, Stephen E Gitelman, Mario R Ehlers, Peter A Gottlieb, Carla J Greenbaum, William Hagopian, Karen D Boyle, Lynette Keyes-Elstein, Sudeepta Aggarwal, Deborah Phippard,[...]. Diabetes 2013
180
5

High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database.
Sabita S Soedamah-Muthu, John H Fuller, Henrietta E Mulnier, Veena S Raleigh, Ross A Lawrenson, Helen M Colhoun. Diabetes Care 2006
232
5


Autoreactive T cells in type 1 diabetes.
Alberto Pugliese. J Clin Invest 2017
109
5

Autoimmune aspects of type 2 diabetes mellitus - a mini-review.
Bianca K Itariu, Thomas M Stulnig. Gerontology 2014
51
5

Targeting Interleukin-6 Signaling in Clinic.
Sujin Kang, Toshio Tanaka, Masashi Narazaki, Tadamitsu Kishimoto. Immunity 2019
185
5

How does type 1 diabetes develop?: the notion of homicide or β-cell suicide revisited.
Mark A Atkinson, Jeffrey A Bluestone, George S Eisenbarth, Matthias Hebrok, Kevan C Herold, Domenico Accili, Massimo Pietropaolo, Peter R Arvan, Matthias Von Herrath, Dorene S Markel,[...]. Diabetes 2011
131
5

Reduction of visceral fat by liraglutide is associated with ameliorations of hepatic steatosis, albuminuria, and micro-inflammation in type 2 diabetic patients with insulin treatment: a randomized control trial.
Ryotaro Bouchi, Yujiro Nakano, Tatsuya Fukuda, Takato Takeuchi, Masanori Murakami, Isao Minami, Hajime Izumiyama, Koshi Hashimoto, Takanobu Yoshimoto, Yoshihiro Ogawa. Endocr J 2017
40
5


Regulatory T Cell Responses in Participants with Type 1 Diabetes after a Single Dose of Interleukin-2: A Non-Randomised, Open Label, Adaptive Dose-Finding Trial.
John A Todd, Marina Evangelou, Antony J Cutler, Marcin L Pekalski, Neil M Walker, Helen E Stevens, Linsey Porter, Deborah J Smyth, Daniel B Rainbow, Ricardo C Ferreira,[...]. PLoS Med 2016
61
5

Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function.
Jordan Rowlands, Julian Heng, Philip Newsholme, Rodrigo Carlessi. Front Endocrinol (Lausanne) 2018
56
5

The challenge of modulating β-cell autoimmunity in type 1 diabetes.
Mark A Atkinson, Bart O Roep, Amanda Posgai, Daniel C S Wheeler, Mark Peakman. Lancet Diabetes Endocrinol 2019
46
5

Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetes.
Ronnie Aronson, Peter A Gottlieb, Jens S Christiansen, Thomas W Donner, Emanuele Bosi, Bruce W Bode, Paolo Pozzilli. Diabetes Care 2014
67
5

The healthy exocrine pancreas contains preproinsulin-specific CD8 T cells that attack islets in type 1 diabetes.
Christine Bender, Teresa Rodriguez-Calvo, Natalie Amirian, Ken T Coppieters, Matthias G von Herrath. Sci Adv 2020
9
11

Concordance for islet autoimmunity among monozygotic twins.
Maria J Redondo, Joy Jeffrey, Pamela R Fain, George S Eisenbarth, Tihamer Orban. N Engl J Med 2008
142
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.